These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 33992132)

  • 41. What Are COVID-19 Vaccines?
    Hartert TV; Sockrider M
    Am J Respir Crit Care Med; 2021 May; 203(9):P22-P23. PubMed ID: 33759735
    [No Abstract]   [Full Text] [Related]  

  • 42. Two new vaccines deliver good and bad news for the pandemic.
    Cohen J
    Science; 2021 Feb; 371(6529):548-549. PubMed ID: 33542114
    [No Abstract]   [Full Text] [Related]  

  • 43. International COVID-19 vaccine inequality amid the pandemic: Perpetuating a global crisis?
    Tatar M; Shoorekchali JM; Faraji MR; Wilson FA
    J Glob Health; 2021 Jul; 11():03086. PubMed ID: 34221356
    [No Abstract]   [Full Text] [Related]  

  • 44. COVID-19 pandemic and international travel: Turkey's experience.
    Ozaras R; Leblebicioglu H
    Travel Med Infect Dis; 2021; 40():101972. PubMed ID: 33450406
    [No Abstract]   [Full Text] [Related]  

  • 45. 2020 Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics.
    Wilensky GR
    JAMA; 2021 Mar; 325(11):1029-1030. PubMed ID: 33724314
    [No Abstract]   [Full Text] [Related]  

  • 46. Key populations for early COVID-19 immunization: preliminary guidance for policy.
    Ismail SJ; Zhao L; Tunis MC; Deeks SL; Quach C;
    CMAJ; 2020 Nov; 192(48):E1620-E1632. PubMed ID: 33144317
    [No Abstract]   [Full Text] [Related]  

  • 47. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.
    Soo RJJ; Chiew CJ; Ma S; Pung R; Lee V
    Emerg Infect Dis; 2020 Aug; 26(8):1933-1935. PubMed ID: 32339092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The necessity for intra-action reviews during the COVID-19 pandemic.
    Mayigane LN; de Vázquez CC; Vente C; Charles D; Copper FA; Bell A; Njenge HK; Schmidt T; Samhouri D; Htike MM; Kato M; Stephen M; Van Kerkhove MD; Chungong S
    Lancet Glob Health; 2020 Dec; 8(12):e1451-e1452. PubMed ID: 33038949
    [No Abstract]   [Full Text] [Related]  

  • 49. Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere.
    Heriot GS; Jamrozik E
    Med J Aust; 2021 Mar; 214(4):150-152.e1. PubMed ID: 33550606
    [No Abstract]   [Full Text] [Related]  

  • 50. Vaccine hesitancy and COVID-19 vaccination in Hong Kong.
    Chan PKS; Wong MCS; Wong ELY
    Hong Kong Med J; 2021 Apr; 27(2):90-91. PubMed ID: 33879624
    [No Abstract]   [Full Text] [Related]  

  • 51. Can COVID-19 vaccines stop the pandemic?
    Lau CS
    Hong Kong Med J; 2021 Apr; 27(2):84-85. PubMed ID: 33879622
    [No Abstract]   [Full Text] [Related]  

  • 52. Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China.
    An Z; Wang F; Pan A; Yin Z; Rodewald L; Feng Z
    BMJ; 2021 Dec; 375():e066125. PubMed ID: 34853010
    [No Abstract]   [Full Text] [Related]  

  • 53. Ensure Palestinians have access to COVID-19 vaccines.
    Martin S; Arawi T
    Lancet; 2021 Feb; 397(10276):791-792. PubMed ID: 33577758
    [No Abstract]   [Full Text] [Related]  

  • 54. Weathering COVID-19 storm: Successful control measures of five Asian countries.
    Lu N; Cheng KW; Qamar N; Huang KC; Johnson JA
    Am J Infect Control; 2020 Jul; 48(7):851-852. PubMed ID: 32360746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Social Workers and the National Strategy for the COVID-19 Response and Pandemic Preparedness.
    Evans EJ
    Health Soc Work; 2021 Jun; 46(2):89-91. PubMed ID: 33930125
    [No Abstract]   [Full Text] [Related]  

  • 56. Towards a European strategy to address the COVID-19 pandemic.
    Priesemann V; Balling R; Bauer S; Beutels P; Valdez AC; Cuschieri S; Czypionka T; Dumpis U; Glaab E; Grill E; Hotulainen P; Iftekhar EN; Krutzinna J; Lionis C; Machado H; Martins C; McKee M; Pavlakis GN; Perc M; Petelos E; Pickersgill M; Prainsack B; Rocklöv J; Schernhammer E; Szczurek E; Tsiodras S; Van Gucht S; Willeit P
    Lancet; 2021 Sep; 398(10303):838-839. PubMed ID: 34384539
    [No Abstract]   [Full Text] [Related]  

  • 57. Mass immunization and COVID-19: the need for continued primary health care.
    Badrfam R; Zandifar A
    East Mediterr Health J; 2021 Mar; 27(3):312-313. PubMed ID: 33788221
    [No Abstract]   [Full Text] [Related]  

  • 58. Covid mutations: honest approach needed from politicians and scientists on pandemic outlook.
    Dagli M
    BMJ; 2021 Mar; 372():n656. PubMed ID: 33688056
    [No Abstract]   [Full Text] [Related]  

  • 59. COVID-19 vaccines for children in LMICs: another equity issue.
    Kampmann B; Okomo U
    Lancet; 2021 Aug; 398(10302):731-732. PubMed ID: 34339625
    [No Abstract]   [Full Text] [Related]  

  • 60. Impact of Victoria's Stage 3 lockdown on COVID-19 case numbers.
    Saul A; Scott N; Crabb BS; Majumdar SS; Coghlan B; Hellard ME
    Med J Aust; 2020 Dec; 213(11):494-496.e1. PubMed ID: 33230817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.